- Agilent Technologies Inc. (A, Financial) posted a 6% revenue growth in Q2 FY2025, reaching $1.67 billion.
- Non-GAAP EPS rose by 7% to $1.31, while GAAP EPS fell to $0.75, a 29% decline from Q2 2024.
- Forecasts for Q3 2025 anticipate revenue of $1.645 billion to $1.675 billion, with non-GAAP EPS between $1.35 to $1.37.
Agilent Technologies Inc. (A) reported its financial results for the second quarter of fiscal year 2025, ending April 30, 2025. The company achieved a revenue of $1.67 billion, marking a 6.0% increase compared to the same quarter in 2024. On a core basis, excluding currency impacts and recent acquisitions, revenue grew by 5.3% year-over-year.
The company's GAAP net income for the quarter was $215 million, with earnings per share (EPS) of $0.75, reflecting a 29% decrease from the second quarter of 2024. However, non-GAAP net income was reported at $373 million, or $1.31 per share, a 7% increase compared to the same period in the previous year.
Agilent's full-year revenue forecast for fiscal year 2025 now stands between $6.73 billion and $6.81 billion, translating to a reported growth of 3.4% to 4.6%. Non-GAAP EPS for the year is projected to be in the range of $5.54 to $5.61.
For the third quarter of fiscal year 2025, Agilent anticipates revenue in the range of $1.645 billion to $1.675 billion, which would represent a reported growth of 4.2% to 6.1%. The non-GAAP EPS for Q3 is expected to be between $1.35 and $1.37 per share.
The Life Sciences and Diagnostics Markets Group generated $654 million in revenue, up 8% from the previous year, while the Agilent CrossLab Group (ACG) saw a 7% growth with $713 million in revenue. The Applied Markets Group noted a slight decline, with revenue falling 1% to $301 million.
Agilent's CEO, Padraig McDonnell, credited the company's Ignite Transformation initiative for driving financial success and strengthening Agilent's market position in a dynamically changing environment.
